BNT317

· BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT317, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors [Phase 1]